Information is Power!

Avastin Extends Progression-Free Survival By 39% In Women With Previously Untreated Ovarian Cancer

ASCO Ovarian Cancer News:

Drug keeps ovarian cancer in check, study finds
In a study of 1,873 women with untreated ovarian cancer, Avastin extended progression-free survival by 39% compared with standard chemotherapy alone.

Read this article by Thomas H. Maugh II of the Los Angeles Times on the Chicago Tribune’s Website (not quite sure why) by going to:
Avastin Extends Progression-Free Survival.

Feel good and keep smiling! Pat

Liked this article? Share it! Information is power!

avastin, ovarian cancer

2 Comments → “Avastin Extends Progression-Free Survival By 39% In Women With Previously Untreated Ovarian Cancer”

  1. Rebecca Weber 1 year ago   Reply

    Always nice to know considering Patti's history. Keep resting Pat.

  2. Pat and Pattie Killingsworth 1 year ago   Reply

    Thanks, Rebecca! How fortunate she is to still be cancer free almost seven years after her surgery and chemotherapy. Lots of Taxol for six months… Yuck! Pat

Leave a Reply